| The stable and healthy development of the pharmaceutical manufacturing industry is not only related to the lifeline of the national economy,but also related to the safety of people’s lives.However,the current social responsibility performance of the pharmaceutical industry is still at a less optimistic level.Due to the frequent occurrence of medical problems,the social responsibility performance of pharmaceutical companies has attracted more and more attention.How can pharmaceutical companies perform social responsibility and corporate performance?Seeking a balance between maximization has become the focus of current research.The thesis first analyzes the current social responsibility performance of the pharmaceutical industry.Through the analysis of the current status of the industry,it can be seen that the current implementation of the social responsibility of the pharmaceutical industry is not in place.Then,based on the seven key stakeholder dimensions,the mechanism of social responsibility performance and corporate performance is explained from the inevitability and interaction of the impact,and a virtuous cycle mechanism diagram between pharmaceutical corporate social responsibility performance and corporate performance is constructed..Finally,based on the 2011-2018 financial data of Watson Bio,based on the event research method,the detailed analysis and elaboration of the impact of social responsibility performance on market performance and financial performance and its impact path,proved the fulfillment of social responsibility of pharmaceutical companies and The feasibility of reaching a balance point between corporate performance allows other pharmaceutical companies to learn the lessons of Watson Bio in fulfilling their social responsibilities,thereby enhancing their enthusiasm and initiative in fulfilling their social responsibilities.Through relevant theoretical analysis and case analysis of the "problem vaccine incident",the following conclusions can be drawn:(1)The performance of social responsibility of pharmaceutical companies has a positive effect on corporate performance,and the performance of social responsibility is poor,and corporate performance will also be Correspondingly lower,and vice versa;(2)The impact between the fulfillment of social responsibility of pharmaceutical companies and corporate performance is interdependent,and the positive social responsibility performance of pharmaceutical companies has satisfied key stakeholders,so they have invested their resources in During the operation of the enterprise,the enterprise obtains higher performance;at the same time,at the request of stakeholders,pharmaceutical companies also need to invest more resources in the fulfillment of social responsibility;(3)for the social responsibility of pharmaceutical enterprises The problems in the situation should be urged from the three aspects of enterprise self-discipline,government guidance,and social supervision to realize the transition from passively taking social responsibility to actively fulfilling social responsibility,so as to achieve the goal of promoting social harmony and stable sustainable development. |